Table 2: The Analysis of Improvement of renal damage indices.

Renal damage indices and comparison between the groupsNo. of studiesWMD [95% CI] value

β 2-MG
 Astragalus versus glucose injection [10]1−15.14 [−21.61, −8.67]
mAlb
 Astragalus versus glucose injection [10]1−28.4 [−47.67, −9.15]
 Astragalus plus Telmisartan, Plendil versus Telmisartan, and Plendil [11]1−4.20 [−7.47, −0.93]
eGFR
 Astragalus plus Telmisartan, Plendil versus Telmisartan, and Plendil [11]14.10 [−2.38, 10.58]
pulse pressure
 Astragalus plus Telmisartan, Plendil versus Telmisartan, and Plendil [11]1−7.00 [−11.56, −2.44]
SBP
 Astragalus plus Telmisartan, Plendil versus Telmisartan, and Plendil [11]1−21.70 [−31.24, −12.16]
DBP
 Astragalus plus Telmisartan, Plendil versus Telmisartan, and Plendil [11]1−4.20 [−11.02, 2.62]
serum potassium
 Astragalus plus Telmisartan, Plendil versus Telmisartan, and Plendil [11]1−0.08[−0.28, 0.12]
twenty-four hours urinary protein content
 Astragalus plus Telmisartan, Plendil versus Telmisartan, and Plendil [11]1−0.05 [−0.07, −0.04]
 Astragalus plus Lotensin, Plendil versus Lotensin, and Plendil [13]1−0.21 [−0.50, 0.08]
BUN
 Astragalus versus prostaglandin [12]1−7.39 [−9.83, −4.95]
Scr
 Astragalus versus prostaglandin [12]1−3.37 [46.05, 39.31]
Ccr
 Astragalus versus prostaglandin [12]16.84 [4.57, 9.11]